Anthony W Castleberry1,2, Brian R Englum1,3, Laurie D Snyder4, Mathias Worni1,5, Asishana A Osho6, Brian C Gulack1,3, Scott M Palmer4, R Duane Davis1,2, Matthew G Hartwig1,2. 1. 1 Department of Surgery. 2. 2 Division of Cardiovascular and Thoracic Surgery, and. 3. 3 Duke Clinical Research Institute, Durham, North Carolina. 4. 4 Division of Pulmonary and Critical Care, Duke University Medical Center, Durham, North Carolina. 5. 5 Department of Visceral Surgery and Medicine, Inselspital, University of Berne, Berne, Switzerland; and. 6. 6 Department of General Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
RATIONALE: The use of 6-minute-walk distance (6MWD) as an indicator of exercise capacity to predict postoperative survival in lung transplantation has not previously been well studied. OBJECTIVES: To evaluate the association between 6MWD and postoperative survival following lung transplantation. METHODS: Adult, first time, lung-only transplantations per the United Network for Organ Sharing database from May 2005 to December 2011 were analyzed. Kaplan-Meier methods and Cox proportional hazards modeling were used to determine the association between preoperative 6MWD and post-transplant survival after adjusting for potential confounders. A receiver operating characteristic curve was used to determine the 6MWD value that provided maximal separation in 1-year mortality. A subanalysis was performed to assess the association between 6MWD and post-transplant survival by disease category. MEASUREMENTS AND MAIN RESULTS: A total of 9,526 patients were included for analysis. The median 6MWD was 787 ft (25th-75th percentiles = 450-1,082 ft). Increasing 6MWD was associated with significantly lower overall hazard of death (P < 0.001). Continuous increase in walk distance through 1,200-1,400 ft conferred an incremental survival advantage. Although 6MWD strongly correlated with survival, the impact of a single dichotomous value to predict outcomes was limited. All disease categories demonstrated significantly longer survival with increasing 6MWD (P ≤ 0.009) except pulmonary vascular disease (P = 0.74); however, the low volume in this category (n = 312; 3.3%) may limit the ability to detect an association. CONCLUSIONS: 6MWD is significantly associated with post-transplant survival and is best incorporated into transplant evaluations on a continuous basis given limited ability of a single, dichotomous value to predict outcomes.
RATIONALE: The use of 6-minute-walk distance (6MWD) as an indicator of exercise capacity to predict postoperative survival in lung transplantation has not previously been well studied. OBJECTIVES: To evaluate the association between 6MWD and postoperative survival following lung transplantation. METHODS: Adult, first time, lung-only transplantations per the United Network for Organ Sharing database from May 2005 to December 2011 were analyzed. Kaplan-Meier methods and Cox proportional hazards modeling were used to determine the association between preoperative 6MWD and post-transplant survival after adjusting for potential confounders. A receiver operating characteristic curve was used to determine the 6MWD value that provided maximal separation in 1-year mortality. A subanalysis was performed to assess the association between 6MWD and post-transplant survival by disease category. MEASUREMENTS AND MAIN RESULTS: A total of 9,526 patients were included for analysis. The median 6MWD was 787 ft (25th-75th percentiles = 450-1,082 ft). Increasing 6MWD was associated with significantly lower overall hazard of death (P < 0.001). Continuous increase in walk distance through 1,200-1,400 ft conferred an incremental survival advantage. Although 6MWD strongly correlated with survival, the impact of a single dichotomous value to predict outcomes was limited. All disease categories demonstrated significantly longer survival with increasing 6MWD (P ≤ 0.009) except pulmonary vascular disease (P = 0.74); however, the low volume in this category (n = 312; 3.3%) may limit the ability to detect an association. CONCLUSIONS: 6MWD is significantly associated with post-transplant survival and is best incorporated into transplant evaluations on a continuous basis given limited ability of a single, dichotomous value to predict outcomes.
Authors: Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2011-10 Impact factor: 10.247
Authors: Thida Win; Arlene Jackson; Linda Sharples; Ashley M Groves; Francis C Wells; Andrew J Ritchie; Clare M Laroche Journal: Chest Date: 2005-04 Impact factor: 9.410
Authors: Anthony W Castleberry; Mathias Worni; Maragatha Kuchibhatla; Shu S Lin; Laurie D Snyder; Scott L Shofer; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2013-07-18 Impact factor: 4.330
Authors: T Martinu; M A Babyak; C F O'Connell; R M Carney; E P Trulock; R D Davis; J A Blumenthal; S M Palmer Journal: Am J Transplant Date: 2008-07 Impact factor: 8.086
Authors: Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi Journal: J Cardiothorac Vasc Anesth Date: 2018-08-09 Impact factor: 2.628
Authors: Jonathan P Singer; Joshua M Diamond; Michaela R Anderson; Patricia P Katz; Ken Covinsky; Michelle Oyster; Tatiana Blue; Allison Soong; Laurel Kalman; Pavan Shrestha; Selim M Arcasoy; John R Greenland; Lori Shah; Jasleen Kukreja; Nancy P Blumenthal; Imaani Easthausen; Jeffrey A Golden; Amika McBurnie; Ed Cantu; Joshua Sonett; Steven Hays; Hilary Robbins; Kashif Raza; Matthew Bacchetta; Rupal J Shah; Frank D'Ovidio; Aida Venado; Jason D Christie; David J Lederer Journal: Am J Transplant Date: 2018-05-14 Impact factor: 8.086
Authors: Emily Siu Clausen; Courtney Frankel; Scott M Palmer; Laurie D Snyder; Patrick J Smith Journal: J Heart Lung Transplant Date: 2018-07-29 Impact factor: 10.247
Authors: Jonathan P Singer; Allison Soong; Allan Bruun; Ayana Bracha; Greg Chin; Steven R Hays; Jasleen Kukreja; Julia Rigler; Jeff A Golden; John R Greenland; Chris Garvey Journal: Clin Transplant Date: 2018-06-20 Impact factor: 2.863
Authors: Isabelle Delanote; Wim A Wuyts; Jonas Yserbyt; Eric K Verbeken; Geert M Verleden; Robin Vos Journal: BMC Pulm Med Date: 2016-11-18 Impact factor: 3.317
Authors: Stephen J Halliday; Li Wang; Chang Yu; Brian P Vickers; John H Newman; Richard D Fremont; Luis E Huerta; Evan L Brittain; Anna R Hemnes Journal: Respir Med Date: 2020-03-19 Impact factor: 3.415